Indian Wilson Disease Market size stood at USD XX Billion in 2019 and is projected to reach USD XX Billion by 2028, exhibiting a CAGR of XX% during the forecast period.
Wilson’s disease is one of the genetic disorder which is caused due to loss of function of the ATP7B copper-binding protein that may lead to impaired copper transport and excretion, which may result in accumulation of free copper in the bloodstream that may result in damage of liver, brain, and other organs. Symptoms that appears are psychiatric, hepatitis or neurological symptoms. The patients usually find difficulty in various activities like talking, swallowing and walking. They also suffer from mental illness such as aggression, depression or suicidal thoughts. Women suffering from WD led to irregular mensuration or infertility and miscarriage. Wilson disease is found in the individual of age between 3 – 60 years, whereas the chance of child inheriting autosomal recessive mutation from both the parent by gene mutation is 25% or one in four ratio.
Increasing the implementation of the various patient assistance programmes, the technological advancements which allows early detection and the increasing awareness of Wilson’s Disease are driving the Wilson’s Disease market. Increase in healthcare expenditure and government support is acting as the opportunity for the Wilson’s disease market, in addition, initiatives taken by the nation to work on the diagnosis and treatment for WD patients is also enhancing the Wilson’s disease market growth in India.